ArimaDex Maker Pulls Supplement From The Market
Following an FDA investigation which found trace amounts of a contaminant — an aromatase inhibitor — in the “muscle building” supplement ArimaDex, the manufacturer Genetic Edge Technology voluntarily pulled the supplement off the market. Aromatase inhibitors are a class of drugs that block the synthesis of estrogen, which have been used in the treatment of breast and ovarian cancer in postmenopausal women.
